Cancer Research Cell Death Mechanisms and Cancer Therapy  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, C.
Right arrow Articles by Lakhani, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, C.
Right arrow Articles by Lakhani, S. R.
[Cancer Research 64, 3037-3045, May 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Expression Profiling of Purified Normal Human Luminal and Myoepithelial Breast Cells

Identification of Novel Prognostic Markers for Breast Cancer

Chris Jones1, Alan Mackay2, Anita Grigoriadis2, Antonio Cossu3, Jorge S. Reis-Filho1, Laura Fulford1,4, Tim Dexter1, Susan Davies2, Karen Bulmer1, Emily Ford1, Suzanne Parry1, Mario Budroni5, Giuseppe Palmieri6, A. Munro Neville2, Michael J. O’Hare2 and Sunil R. Lakhani1,7

1 The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom; 2 Ludwig Institute for Cancer Research/University College London Breast Cancer Laboratory, University College London, London, United Kingdom; 3 Istituto di Anatomia Patologica, Università di Sassari, Italy; 4 Ludwig Institute for Cancer Research, University College London, United Kingdom; 5 Servizio Epidemiologia, Sassari, Italy; 6 Istituto di Chimica Biomolecolare, Alghero, Italy; and 7 The Royal Marsden Hospital, London, United Kingdom

The normal duct-lobular system of the breast is lined by two epithelial cell types, inner luminal secretory cells and outer contractile myoepithelial cells. We have generated comprehensive expression profiles of the two normal cell types, using immunomagnetic cell separation and gene expression microarray analysis. The cell-type specificity was confirmed at the protein level by immunohistochemistry in normal breast tissue. New prognostic markers for survival were identified when the luminal- and myoepithelial-specific molecules were evaluated on breast tumor tissue microarrays. Nuclear expression of luminal epithelial marker galectin 3 correlated with a shorter overall survival in these patients, and the expression of SPARC (osteonectin), a myoepithelial marker, was an independent marker of poor prognosis in breast cancers as a whole. These data provide a framework for the interpretation of breast cancer molecular profiling experiments, the identification of potential new diagnostic markers, and development of novel indicators of prognosis.




This article has been cited by other articles:


Home page
INT J SURG PATHOLHome page
F. Correa Geyer and J. S. Reis-Filho
Microarray-based Gene Expression Profiling as a Clinical Tool for Breast Cancer Management: Are We There Yet?
International Journal of Surgical Pathology, August 1, 2009; 17(4): 285 - 302.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Yang, D. R. Bielenberg, S. J. Rodig, R. Doiron, M. C. Clifton, A. L. Kung, R. K. Strong, D. Zurakowski, and M. A. Moses
Lipocalin 2 promotes breast cancer progression
PNAS, March 10, 2009; 106(10): 3913 - 3918.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
P. D. Maningat, P. Sen, M. Rijnkels, A. L. Sunehag, D. L. Hadsell, M. Bray, and M. W. Haymond
Gene expression in the human mammary epithelium during lactation: the milk fat globule transcriptome
Physiol Genomics, March 3, 2009; 37(1): 12 - 22.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Sangaletti, E. Di Carlo, S. Gariboldi, S. Miotti, B. Cappetti, M. Parenza, C. Rumio, R. A. Brekken, C. Chiodoni, and M. P. Colombo
Macrophage-Derived SPARC Bridges Tumor Cell-Extracellular Matrix Interactions toward Metastasis
Cancer Res., November 1, 2008; 68(21): 9050 - 9059.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Helleman, M. P.H.M. Jansen, K. Ruigrok-Ritstier, I. L. van Staveren, M. P. Look, M. E. Meijer-van Gelder, A. M. Sieuwerts, J. G.M. Klijn, S. Sleijfer, J. A. Foekens, et al.
Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response
Clin. Cancer Res., September 1, 2008; 14(17): 5555 - 5564.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Zhang, F. Behbod, R. L. Atkinson, M. D. Landis, F. Kittrell, D. Edwards, D. Medina, A. Tsimelzon, S. Hilsenbeck, J. E. Green, et al.
Identification of Tumor-Initiating Cells in a p53-Null Mouse Model of Breast Cancer
Cancer Res., June 15, 2008; 68(12): 4674 - 4682.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
E Korsching, S S Jeffrey, W Meinerz, T Decker, W Boecker, and H Buerger
Basal carcinoma of the breast revisited: an old entity with new interpretations
J. Clin. Pathol., May 1, 2008; 61(5): 553 - 560.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Sarrio, S. M. Rodriguez-Pinilla, D. Hardisson, A. Cano, G. Moreno-Bueno, and J. Palacios
Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
Cancer Res., February 15, 2008; 68(4): 989 - 997.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
F. Meslin, R. Conforti, C. Mazouni, N. Morel, G. Tomasic, F. Drusch, M. Yacoub, J. C. Sabourin, J. Grassi, S. Delaloge, et al.
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer
Ann. Onc., November 1, 2007; 18(11): 1793 - 1798.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Huper and J. R. Marks
Isogenic Normal Basal and Luminal Mammary Epithelial Isolated by a Novel Method Show a Differential Response to Ionizing Radiation
Cancer Res., April 1, 2007; 67(7): 2990 - 3001.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. R. Infante, H. Matsubayashi, N. Sato, J. Tonascia, A. P. Klein, T. A. Riall, C. Yeo, C. Iacobuzio-Donahue, and M. Goggins
Peritumoral Fibroblast SPARC Expression and Patient Outcome With Resectable Pancreatic Adenocarcinoma
J. Clin. Oncol., January 20, 2007; 25(3): 319 - 325.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
K. E. Sleeman, H. Kendrick, D. Robertson, C. M. Isacke, A. Ashworth, and M. J. Smalley
Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland
J. Cell Biol., January 1, 2007; 176(1): 19 - 26.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Savage, M. B.K. Lambros, D. Robertson, R. L. Jones, C. Jones, A. Mackay, M. James, J. L. Hornick, E. M. Pereira, F. Milanezi, et al.
Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis
Clin. Cancer Res., January 1, 2007; 13(1): 90 - 101.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C L Wilson, A H Sims, A Howell, C J Miller, and R B Clarke
Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 617 - 628.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. D. Kennedy, J. J. Gorski, J. E. Quinn, G. E. Stewart, C. R. James, S. Moore, K. Mulligan, E. D. Emberley, T. F. Lioe, P. J. Morrison, et al.
BRCA1 and c-Myc Associate to Transcriptionally Repress Psoriasin, a DNA Damage-Inducible Gene
Cancer Res., November 15, 2005; 65(22): 10265 - 10272.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. A. Ferguson, M. R. Muenster, Q. Zang, J. A. Spencer, J. J. Schageman, Y. Lian, H. R. Garner, R. B. Gaynor, J. W. Huff, A. Pertsemlidis, et al.
Selective Identification of Secreted and Transmembrane Breast Cancer Markers using Escherichia coli Ampicillin Secretion Trap
Cancer Res., September 15, 2005; 65(18): 8209 - 8217.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. R. Lakhani, J. S. Reis-Filho, L. Fulford, F. Penault-Llorca, M. van der Vijver, S. Parry, T. Bishop, J. Benitez, C. Rivas, Y.-J. Bignon, et al.
Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype
Clin. Cancer Res., July 15, 2005; 11(14): 5175 - 5180.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. P.H.M. Jansen, J. A. Foekens, I. L. van Staveren, M. M. Dirkzwager-Kiel, K. Ritstier, M. P. Look, M. E. Meijer-van Gelder, A. M. Sieuwerts, H. Portengen, L. C.J. Dorssers, et al.
Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling
J. Clin. Oncol., February 1, 2005; 23(4): 732 - 740.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. N. Kristensen, T. Sorlie, J. Geisler, A. Langerod, N. Yoshimura, R. Karesen, N. Harada, P.E. Lonning, and A.-L. Borresen-Dale
Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications
Clin. Cancer Res., January 15, 2005; 11(2): 878s - 883s.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.